Complex Biologics
for
Complicated Diseases

At Salubris Biotherapeutics, Inc. (SalubrisBio)

We work to develop innovative and transformative therapeutic molecules which provide clinically meaningful improvements in disease burden and quality of life to patients with significant medical needs.

What We Do

SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.

Our Research

SalubrisBio’s focus areas are cardiovascular disease, oncology, and neurodegenerative disease, three leading causes of death in the world today.

Oncology

Cardiovascular

Neurology

About Us

We are a team of biotechnology industry experts brought together by our passion and commitment to excellence in the discovery and development of novel therapies.